Medical Condition News

RSS

Toronto Rehab, Calgary Stroke Program receive Distinction status from Accreditation Canada

The Calgary Stroke Program continues to be one of the top stroke programs in Canada and today received a second "Stroke Services Distinction" award from Accreditation Canada. It remains the only comprehensive stroke program in the country with this status.

2 Oct 2012

New computerized approach for quantitative estimation of osteoporosis

A computerized approach to examining patient bone X-rays for diagnosis of osteoporosis could side-step the subjectivity associated with visual examination, according to a new research paper in the International Journal of Biomedical Engineering and Technology published in October.

2 Oct 2012

Anemia now confirmed as risk factor for illness and even death following cardiac surgery

Anemia is now confirmed as a risk factor for illness and even death following cardiac surgery, according to a study published in the October 2012 issue of The Annals of Thoracic Surgery.

2 Oct 2012

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.

2 Oct 2012

Self-harming and premature death: an interview with Prof Keith Hawton, University of Oxford Centre for Suicide Research

“Self-harm” is the term used in the UK, much of Europe and elsewhere, to describe intentional self-poisoning or self-injury. Thus it includes overdoses, attempted hanging, self-cutting etc.

2 Oct 2012

Thermal imaging camera monitors pain processing in patients suffering from small fiber neuropathy

Early results from the NeuroSIPE* programme 'Beyond Pain' project, in research funded by the Dutch Technology Foundation STW, demonstrate how a FLIR SC5600 thermal imaging camera has been used as an effective, non-invasive tool for monitoring of pain processing in the central nervous system of patients suffering from small fiber neuropathy.

2 Oct 2012

Autoimmune disease myasthenia gravis halted in mice

Working with mice, Johns Hopkins researchers say they have developed a gene-based therapy to stop the rodent equivalent of the autoimmune disease myasthenia gravis by specifically targeting the destructive immune response the disorder triggers in the body.

1 Oct 2012

Medication management, wound care part of new normal for caregivers

Today, AARP Public Policy Institute (PPI) and the United Hospital Fund (UHF) released a new report that finds 46 percent of family caregivers perform medical and nursing tasks for care recipients with multiple chronic physical and cognitive conditions.

1 Oct 2012

Addition of ficlatuzumab to gefitinib may be effective in select subsets of patients with NSCLC

AVEO Oncology today announced that detailed results from an exploratory, randomized Phase 2 study evaluating the combination of ficlatuzumab, the company's HGF inhibitory antibody, and gefitinib compared to gefitinib monotherapy in previously untreated Asian subjects with non-small cell lung cancer (NSCLC) were presented at the 2012 Congress of the European Society for Medical Oncology (ESMO).

1 Oct 2012

Five prominent surgeons receive Honorary Fellowship from ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to five prominent surgeons from Japan, the Philippines, Mexico, England, and Belgium during Convocation ceremonies that preceded the official opening of the 2012 ACS Annual Clinical Congress.

1 Oct 2012

Medistem initiates collaboration with Superview Biotechnology

Medistem Inc announced today the initiation of a collaboration with Superview Biotechnology Co. Ltd, a subsidiary of Yinhuan Holding Co from Yixing, China.

1 Oct 2012

Takeda, Seattle Genetics announce preliminary data from brentuximab vedotin phase I study on sALCL

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Seattle Genetics, Inc., today announced preliminary data from one arm of a three arm phase I, open-label, multicenter study designed to determine the safety and activity of sequential and combination treatment approaches of brentuximab vedotin with CHOP or CH-P chemotherapy in newly diagnosed patients with CD30-positive mature T- and NK- cell lymphomas.

1 Oct 2012

New evidence-based guidelines for management of acute low back pain

According to an article in the October issue of the Journal of the American College of Radiology, radiologists at Emory University Hospital, in Atlanta, and Georgia Health Sciences University, in Augusta, Ga., have developed evidence-based guidelines to assist physicians with the process of managing patients with acute low back pain.

1 Oct 2012

Nova Scotia's stroke strategy improves care for three rural health districts

Stroke patients in rural Nova Scotia receive better treatment and are less likely to end up in long-term care facilities than they were before the province's stroke strategy was rolled out in 2008, according to a study presented today at the Canadian Stroke Congress.

1 Oct 2012

Emergency medicine residency programs need more formal stroke training

Medical residents training to work in the emergency department need more formal stroke training, says a study presented today at the Canadian Stroke Congress, noting that, as the first point of contact in stroke care, they see nearly 100 per cent of stroke patients taken to hospital.

1 Oct 2012

Most people completely unaware of aphasia

Most people are completely unaware of one of stroke's most common, debilitating but invisible impairments, according to the first awareness survey of its kind in Canada released today at the Canadian Stroke Congress.

1 Oct 2012

Inhibiting DUSP6 protein can restore immune cells’ responsiveness to a more youthful state

The older we get, the weaker our immune systems tend to become, leaving us vulnerable to infectious diseases and cancer and eroding our ability to benefit from vaccination. Now Stanford University School of Medicine scientists have found that blocking the action of a single protein whose levels in our immune cells creep steadily upward with age can restore those cells' response to a vaccine.

1 Oct 2012

EC approves Sosei’s Seebri Breezhaler to treat COPD

Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

1 Oct 2012

Home delivery of stroke rehabilitation improves care, eliminates waiting lists and saves costs

Home delivery of stroke rehabilitation improves care, eliminates waiting lists for treatment and saves hundreds of thousands of dollars annually in hospital costs, according to a quality improvement project presented today at the Canadian Stroke Congress.

1 Oct 2012

Cafeteria diet increases risk of stroke or death at a younger age

The fat- and sugar-rich Western diet leads to a lifetime of health problems, dramatically increasing the risk of stroke or death at a younger age, according to a study presented today at the Canadian Stroke Congress.

1 Oct 2012

Medical Condition News

Toronto Rehab, Calgary Stroke Program receive Distinction status from Accreditation Canada

New computerized approach for quantitative estimation of osteoporosis

Anemia now confirmed as risk factor for illness and even death following cardiac surgery

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

Self-harming and premature death: an interview with Prof Keith Hawton, University of Oxford Centre for Suicide Research

Thermal imaging camera monitors pain processing in patients suffering from small fiber neuropathy

Autoimmune disease myasthenia gravis halted in mice

Medication management, wound care part of new normal for caregivers

Addition of ficlatuzumab to gefitinib may be effective in select subsets of patients with NSCLC

Five prominent surgeons receive Honorary Fellowship from ACS

Medistem initiates collaboration with Superview Biotechnology

Takeda, Seattle Genetics announce preliminary data from brentuximab vedotin phase I study on sALCL

New evidence-based guidelines for management of acute low back pain

Nova Scotia's stroke strategy improves care for three rural health districts

Emergency medicine residency programs need more formal stroke training

Most people completely unaware of aphasia

Inhibiting DUSP6 protein can restore immune cells’ responsiveness to a more youthful state

EC approves Sosei’s Seebri Breezhaler to treat COPD

Home delivery of stroke rehabilitation improves care, eliminates waiting lists and saves costs

Cafeteria diet increases risk of stroke or death at a younger age

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News